SpiraCheck is a start-up focussed on developing a multi-cancer early detection breath test for improved cancer survival. Through identification of volatile organic compounds (VOCs) it is intended that the SpiraCheck algorithm will be able to rule-out gastrointestinal and other cancers through one test.
SpiraCheck is a spin-out from Imperial College, London and the work of Professor George Hanna and his team. The SpiraCheck test is being developed to improve the five-year relative survival for gastro-intestinal cancers by increasing the rate of early detection. At the same time, the test should decrease the number of invasive diagnostic tests through better prioritisation, thereby reducing the financial burden of healthcare systems.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Scale Space, 58 Wood Lane, London,england W12 7rz,united Kingdom
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.spiracheck.com
- Keywords
- Medical devices, IVDs, Diagnostics, cancer, oesophageal cancer, oesophagogastric cancer, gastric cancer, pancreatic cancer, esophageal cancer, esophagogastric cancer, colorectal cancer, liver cancer, hepatic cancer, bowel cancer.
- HQ
- London, England
Spiracheck Ltd Questions
Spiracheck Ltd's website is http://www.spiracheck.com
Spiracheck Ltd's LinkedIn profile is https://uk.linkedin.com/company/spiracheck-ltd
Spiracheck Ltd has
1 employees.
View email and phone details for 1
employees at Spiracheck Ltd.
Spiracheck Ltd's industry is
Medical and Diagnostic Laboratories
Spiracheck Ltd's top competitors are
Cipherx Technologies,
Woost,
Radiant Matter,
Ailurus Bio,
Simpedia,
Algreen Ltd.,
Fresh Check: Confirming Hygiene,
P.happi®,
Quantify R&d,
Metsera.
Spiracheck Ltd's categories are Medical and Diagnostic Laboratories
Spiracheck Ltd's founding year is 2016
